1-3 of 3
Estelle Seilles, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Studies Of SL-401, a Targeted Therapy Directed To The Interleukin-3 Receptor (IL3-R), In Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Potent Activity In BPDCN Cell Lines, Primary Tumor, and In An In Vivo Model

Delettre Fanny, PhD, Arthur E. Frankel, MD, Estelle Seilles, PhD, Sabeha Biichle, Bsc, Eric Deconninck, MD, Francis Bonnefoy, PhD, Baptiste Lamarthee, PhD Student, Christopher L. Brooks, PhD, Eric Rowinsky, MD, Philippe Saas, Ph.D., Francine Garnache Ottou, PhD
Journal: Blood
Blood (2013) 122 (21): 3942.
https://doi.org/10.1182/blood.V122.21.3942.3942
Published: 2013
Journal Articles

The IL-3Rα-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm Cells

Fanny Angelot-Delettre, PhD, Arthur E. Frankel, MD, Jen Sing Liu, PhD, Estelle Seilles, PhD, Sabeha Biichle, Bsc, Bernard Drenou, MD, PhD, Mark L. Jacobson, MA, Thomas P. Cirrito, PhD, Arkam Yazid, MD, Eric Deconinck, MD, PhD, Christopher L. Brooks, PhD, Philippe Saas, PhD, Francine Garnache Ottou, PhD
Journal: Blood
Blood (2011) 118 (21): 2588.
https://doi.org/10.1182/blood.V118.21.2588.2588
Published: 2011
Journal Articles

Endothelial Cell-Derived Microparticules (EMPs) Can Induce In Vitro Maturation of Both Plasmocytoid and Myeloid Dendritic Cells.

Francine Garnache-Ottou, PhD, Fanny Angelot, Sabeha Biichle, Joel PLumas, PhD, Francoise Dignat George, PhD, Philippe Saas, PhD, Pierre Tiberghien, MD PhD, Estelle Seilles, PhD
Journal: Blood
Blood (2006) 108 (11): 1273.
https://doi.org/10.1182/blood.V108.11.1273.1273
Published: 2006